EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Opus Genetics, Inc. (IRD) had EBIT Margin of -296.33% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.87M |
|
$-16.52M |
|
-- |
|
$3.87M |
|
$15.32M |
|
$-11.45M |
|
$-5.07M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-16.52M |
|
$-11.45M |
|
$-11.44M |
|
62.22M |
|
62.22M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$50.04M |
|
$0.20M |
|
$0.20M |
|
$50.24M |
|
$7.78M |
|
-- |
|
$27.11M |
|
$34.90M |
|
$15.35M |
|
$15.35M |
|
$15.35M |
|
69.89M |
|
| Cash Flow Statement Financials | |
$-35.25M |
|
-- |
|
$50.02M |
|
$30.32M |
|
$45.09M |
|
$14.77M |
|
$3.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-296.33% |
|
|
EBIT Margin |
-296.33% |
-- |
|
-427.50% |
|
-427.50% |
|
$-35.25M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.94 |
|
46.46 |
|
-107.66% |
|
-107.66% |
|
-32.89% |
|
-107.66% |
|
$0.22 |
|
$-0.57 |
|
$-0.57 |
|